{"entity":{"type":"insider","cik":"0001753143","url":"/insider/0001753143","json_url":"/insider/0001753143.json","name":"Pardo Geoffrey B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2021-07-02","last":"2026-02-11","span_basis":"filed_date"},"name_variants":[{"name":"Pardo Geoffrey B","source":"filing","n_filings":3,"first_seen":"2021-07-02","last_seen":"2026-02-11"}],"transactions":[{"id":6175737,"accession":"0001753143-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001753143-26-000006","line_url":"/filing/0001753143-26-000006#line-2","is_derivative":false,"issuer_cik":"0001753143","issuer_name":"SpyGlass Pharma, Inc.","issuer_ticker":"SGP","issuer_name_source":null,"issuer_url":"/issuer/0001753143","owner_cik":"0001753143","owner_name":"Pardo Geoffrey B","owner_display_name":"Pardo Geoffrey B","owner_url":"/insider/0001753143","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2187513.0,"shares_owned_after_display":"2,187,513","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-09","filed_date":"2026-02-11","scope":"insider"},{"id":5202959,"accession":"0001641172-25-022249","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001641172-25-022249","line_url":"/filing/0001641172-25-022249#line-3","is_derivative":false,"issuer_cik":"0001699350","issuer_name":"SHOULDER INNOVATIONS, INC.","issuer_ticker":"SI","issuer_name_source":null,"issuer_url":"/issuer/0001699350","owner_cik":"0001753143","owner_name":"Pardo Geoffrey B","owner_display_name":"Pardo Geoffrey B","owner_url":"/insider/0001753143","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":2380482.0,"shares_owned_after_display":"2,380,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":4320450,"accession":"0001179110-21-007339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-007339","line_url":"/filing/0001179110-21-007339#line-2","is_derivative":false,"issuer_cik":"0001235912","issuer_name":"CVRx, Inc.","issuer_ticker":"CVRX","issuer_name_source":null,"issuer_url":"/issuer/0001235912","owner_cik":"0001753143","owner_name":"Pardo Geoffrey B","owner_display_name":"Pardo Geoffrey B","owner_url":"/insider/0001753143","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4950000.0,"total_display":"4,950,000.00","total_whole":"4,950,000","shares_owned_after":1829022.0,"shares_owned_after_display":"1,829,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001778922","name":"SpyGlass Pharma, Inc.","url":"/issuer/0001778922","role":"Director","n_filings":1,"first_seen":"2026-02-11","last_seen":"2026-02-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001699350","name":"SHOULDER INNOVATIONS, INC.","url":"/issuer/0001699350","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2025-08-05","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001235912","name":"CVRx, Inc.","url":"/issuer/0001235912","role":"Director","n_filings":1,"first_seen":"2021-07-02","last_seen":"2021-07-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753143","retrieved_at":"2026-08-23T10:14:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}